Anti-BDNF antibody [EPR1292] (Ab108319)

特异性

This product may cross react with the following family members: NGF beta, neurotrophin 3, neurotrophin 4. It was discovered that this antibody exhibited weak cross - reactivity with the NTF3 protein.

Anti-BDNF antibody [EPR1292] (ab108319) was developed by Abcam using patented rabbit monoclonal antibody technology and is validated for use in Flow Cyt (Intra), ICC/IF, IHC-Fr, IHC-P and WB. Anti-BDNF antibody [EPR1292] (ab108319) was first used in a scientific publication in 2012 and has been cited over 481 times in peer reviewed journals. It's performance in Western Blot in human, mouse and rat samples is trusted by the scientific community. Abcam's high quality manufacturing and validation processes ensure Anti-BDNF antibody [EPR1292] (ab108319) has high sensitivity and specificity alongside high lot-to-lot consistency and reproducibility. Anti-BDNF antibody [EPR1292] (ab108319) has 8 independent reviews from customers. Anti-BDNF antibody [EPR1292] (ab108319) specifically detects BDNF (UniProt ID: P23560; Molecular weight: 26kDa) and is sold in 100 µL and 1 mL selling sizes. Conjugation-ready, carrier free format available for antibody clone EPR1292 - ab216443. Antibody clone EPR1292 is also available pre-conjugated to a variety of labels for your convenience - Alexa Fluor ® 488, Alexa Fluor ® 647, Alexa Fluor ® 555 ( ab222113, ab222321, ab305366 ). BDNF (Brain-Derived Neurotrophic Factor) is a key protein in neuro research, particularly for its role in supporting neuronal survival, growth and differentiation. It is crucial for synaptic plasticity, which underlies learning and memory. Researchers use BDNF to study neurodevelopment, neuroprotection and the effects of various interventions on brain health, making it essential for understanding both normal brain function and the pathology of neurodegenerative diseases. Its expression is highly regulated and can be influenced by factors such as exercise and stress. Patented technology Our RabMAb ® technology is a patented hybridoma-based technology for making rabbit monoclonal antibodies. For details on our patents, please refer to RabMAb ® patents. What are the advantages of a recombinant monoclonal antibody? This product is a recombinant monoclonal antibody, which offers several advantages including - High batch-to-batch consistency and reproducibility - Improved sensitivity and specificity - Long-term security of supply - Animal-free batch production For more information, read more on recombinant antibodies.